Up-regulation of the DR5 expression by proteasome inhibitor MG132 augments TRAIL-induced apoptosis in soft tissue sarcoma cell lines (Q84658365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Up-regulation of the DR5 expression by proteasome inhibitor MG132 augments TRAIL-induced apoptosis in soft tissue sarcoma cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Hee-Jeong Cheong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kyu Sang Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

In Sook Woo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jong-Ho Won

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jae Ho Byun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

30 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

Cancer Research and Treatment

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

124-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

9 February 2020

copyright license

start time

30 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).

1 reference

12 December 2020

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

12 December 2020

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

12 December 2020

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

1 reference

12 December 2020

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

12 December 2020

The receptor for the cytotoxic ligand TRAIL

1 reference

12 December 2020

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

12 December 2020

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

12 December 2020

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

12 December 2020

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

12 December 2020

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

12 December 2020

Management of soft tissue sarcomas of the extremities

1 reference

12 December 2020

The proteasome: a suitable antineoplastic target

1 reference

12 December 2020

Overview of cell death signaling pathways

1 reference

12 December 2020

Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy

1 reference

12 December 2020

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells

1 reference

12 December 2020

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

12 December 2020

TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.

1 reference

12 December 2020

Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation

1 reference

12 December 2020

Lethal effect of the anti-Fas antibody in mice

1 reference

12 December 2020

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

12 December 2020

Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.

1 reference

12 December 2020

10.4143/CRT.2011.43.2.124

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811429%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference